{"schema_version":"secwatch.filing_event.v1","accession":"0001100682-26-000142","form_type":"8-K","ticker":"CRL","cik":"0001100682","company_name":"CHARLES RIVER LABORATORIES INTERNATIONAL, INC.","filed_at":"2026-09-24T12:12:10+00:00","discovered_at":"2026-09-24T13:00:03.502281+00:00","generated_at":"2026-09-24T13:03:41.814214+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Charles River unveils 'Pathway to Purpose' strategy; reaffirms 2026 guidance at upper end","bullets":["Announces 'Pathway to Purpose' strategy focused on modernization, scientific portfolio, and client-centric approach.","Expects over $300M cumulative savings from Create the Future program (2027-2030) via automation and AI digital tools.","Reaffirms 2026 guidance: organic revenue growth at upper end of 0%–1%; non-GAAP EPS at upper end of $11.15–$11.45.","Introduces 2030 targets: 5%–7% organic revenue CAGR, ~24% non-GAAP operating margin, low-double-digit EPS CAGR.","Bioanalysis revenue targeted at ~$450M by 2030; Apollo platform now serves 18,000 client users."],"urls":{"canonical":"https://secwatch.observer/filing/0001100682-26-000142","json":"https://secwatch.observer/filing/0001100682-26-000142.json","markdown":"https://secwatch.observer/filing/0001100682-26-000142.md","text":"https://secwatch.observer/filing/0001100682-26-000142.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000142/0001100682-26-000142-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1100682/000110068226000142/crl-20260924.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-24T13:03:41.814214+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}